Hanwha Impact Partners led a $35m Series B financing round in Catalog Technologies, a provider of cutting-edge synthetic biology technologies to the world of information storage and computation. “Catalog’s proprietary approach to writing information into DNA, namely its encoding scheme, is revolutionary in that minimal de novo DNA synthesis is required to store a tremendous amount of information. Because the low speed and high cost of DNA synthesis have traditionally been the bottleneck in this field,” Hyunjun Park Catalog, Co-Founder and CEO.